Comparison of Hyperglycemic Effects of Antenatal Administration of Dexamethasone in Gestational Diabetes: A Study of Recommended Versus Predicted Split Doses Regimens
DOI:
https://doi.org/10.51253/pafmj.v74i2.8955Keywords:
Dexamethasone, Gestational Diabetes Mellitus, Preterm Labour, Respiratory distressAbstract
Objective: To compare three consecutive days of hyperglycemic response following antenatal Dexamethasone regimens of 12mg or 6mg in diet-controlled gestational diabetes, administered for fetal lung maturity.
Study Design: Quasi-experimental study
Place and Duration of Study: Department of Obstetrics and Gynaecology, Combined Military Hospital, Kharian Pakistan, from Oct 2020 to Mar 2021.
Methodology: Forty women who met inclusion criteria were selected and assigned to two Groups. Group-A was administered quartered 24 mg steroids 6 hours daily, and Group-B was administered halved 24mg 12 hours daily. Blood sugar levels (BSL) were recorded before and after meals, thrice a day for three consecutive days, and on proforma.
Results: Among the selected patients, the mean age was 25.5±2.9 years, and the mean gestational age (duration of pregnancy) was 30.3±2.0 weeks. Out of six blood sugar levels recorded daily for three consecutive days, the episodes of hyperglycemia in the (Group-B) 12-hourly steroid dose were found to be less significant than those in the (Group-A) split 6-hourly dose.
Conclusion: The recommended 12 mg, twice-a-day regimen of antenatal corticosteroids was better than the proposed 6mg, four times a day regimen as it caused fewer hyperglycemic episodes in gestational diabetics.
Downloads
References
Jehan I, Harris H, Salat S, Zeb A, Mobeen N, Pasha O, et al.
Neonatal mortality, risk factors and causes: a prospective
population-based cohort study in urban Pakistan. Bull World
Health Organ 2009; 87(2): 130-138.
https://doi.org/10.2471/blt.08.050963
International Association of Diabetes and Pregnancy Study
Groups Consensus Panel; Metzger BE, Gabbe SG, Persson B,
Buchanan TA, Catalano PA, Damm P, et al. International
association of diabetes and pregnancy study groups
recommendations on the diagnosis and classification of
hyperglycemia in pregnancy. Diabetes Care 2010; 33(3): 676-682.
https://doi.org/10.2337/dc09-1848
Takeda A, Martin N, Taylor RS, Taylor SJ. Disease management
interventions for heart failure. Cochrane Database Syst Rev 2019;
(1): CD002752.
https://doi.org/10.1002/14651858.CD002752.pub4
Committee on Obstetric Practice. Committee Opinion No. 713:
Antenatal Corticosteroid Therapy for Fetal Maturation. Obstet
Gynecol 2017; 130(2): e102-e109.
https://doi.org/10.1097/AOG.0000000000002237
Persson B, Hanson U. Neonatal morbidities in gestational
diabetes mellitus. Diabetes Care 1998; 21 Suppl 2: B79-84.
Battarbee AN, Venkatesh KK, Aliaga S, Boggess KA. The
association of pregestational and gestational diabetes with
severe neonatal morbidity and mortality. J Perinatol 2020; 40(2):
-239. https://doi.org/10.1038/s41372-019-0516-5
Wapner R, Jobe AH. Controversy: antenatal steroids. Clin
Perinatol 2011; 38(3): 529-545.
https://doi.org/10.1016/j.clp.2011.06.013
Moyce BL, Dolinsky VW. Maternal β-Cell Adaptations in
Pregnancy and Placental Signalling: Implications for Gestational
Diabetes. Int J Mol Sci 2018; 19(11): 3467.
https://doi.org/10.3390/ijms19113467
ACOG Committee Opinion No. 475: antenatal corticosteroid
therapy for fetal maturation. Obstet Gynecol 2011; 117(2 Pt 1):
-424. https://doi.org/10.1097/AOG.0b013e31820eee00
Mushkat Y, Ascher-Landsberg J, Keidar R, Carmon E, Pauzner
D, David MP. et al. The effect of betamethasone versus
dexamethasone on fetal biophysical parameters. Eur J Obstet
Gynecol Reprod Biol 2001; 97(1): 50-52.
https://doi.org/10.1016/s0301-2115(00)00498-x
Fatima SS, Rehman R, Alam F, Madhani S, Chaudhry B, Khan
TA. et al. Gestational diabetes mellitus and the predisposing
factors. J Pak Med Assoc 2017; 67(2): 261-265.
Dashora U, Murphy HR, Temple RC, Stanley KP, Castro E,
George S, et al; Joint British Diabetes Societies (JBDS) for
Inpatient Care. Managing hyperglycaemia during antenatal
steroid administration, labour and birth in pregnant women
with diabetes. Diabet Med 2018; 35(8): 1005-1010.
https://doi.org/10.1111/dme.13674
American Diabetes Association. 12. Management of Diabetes in
Pregnancy. Diabetes Care 2016; 39 Suppl 1: S94-98.
https://doi.org/10.2337/dc16-S015
Hu Kl, Zhao H, Yu Y, Li R. Kisspeptin as a potential biomarker
throughout pregnancy. Eur J Obstet Gynecol Reprod Biol 2019;
: 261–266. https://doi.org/10.1016/j.ejogrb.2019.07.016
Hill M, Pařízek A, Šimják P, Koucký M, Anderlová K, Krejčí H,
et al. Steroids, steroid associated substances and gestational
diabetes mellitus. Physiol Res 2021; 70(Suppl4): S617-S634.
https://doi.org/10.33549/physiolres.934794
Itoh A, Saisho Y, Miyakoshi K, Fukutake M, Kasuga Y, Ochiai D,
et al. Time-dependent changes in insulin requirement for
maternal glycemic control during antenatal corticosteroid
therapy in women with gestational diabetes: a retrospective
study. Endocr J 2016; 63(1): 101-104.
https://doi.org/10.1507/endocrj.EJ15-0482
Kalra S, Kalra B, Gupta Y. Glycemic management after antenatal
corticosteroid therapy. N Am J Med Sci 2014; 6(2): 71-76.
https://doi.org/10.4103/1947-2714.127744
Faal S, Abedi P, Jahanfar S, Ndeke JM, Mohaghegh Z,
Sharifipour F, et al. Sex hormone binding globulin for prediction
of gestational diabetes mellitus in pre-conception and
pregnancy: A systematic review. Diabetes Res Clin Pract 2019;
: 39-52. https://doi.org/10.1016/j.diabres.2019.04.028
Sukarna N, Tan PC, Hong JGS, Sulaiman S, Omar SZ. Glycemic
control following two regimens of antenatal corticosteroids in
mild gestational diabetes: a randomized controlled trial. Arch
Gynecol Obstet 2021; 304(2): 345-353.
https://doi.org/10.1007/s00404-020-05950-3
Bowe JE, Hill TG, Hunt KF, Smith LI, Simpson SJ, Amiel SA, et
al. A role for placental kisspeptin in β cell adaptation to
pregnancy. JCI Insight. 2019; 4(20): e124540.
https://doi.org/10.1172/jci.insight.124540
Feng Y, Feng Q, Qu H, Song X, Hu J, Xu X, et al. Stress
adaptation is associated with insulin resistance in women with
gestational diabetes mellitus. Nutr Diabetes 2020; 10(1): 4.